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the target lesion during long-term follow-up, DM was associated with significantly
increased other major cardiac ischemic events and a non-statistically significant increase
in mortality. 
1081-55 Influence of Gender on In-Hospital and Long-Term 
Clinical Outcomes Following Percutaneous or Surgical 
Revascularization: A Report From the Arterial 
Revascularization Therapies Study (ARTS)
Vassilis Voudris, Dennis V. Cokkinos, Clemens Disco, Patrick W. Serruys, on Behalf of 
Arterial Revascularization TherapiesStudy (ARTS) Group, Onassis Cardiac Surgery 
Center, Athens, Greece, Thoraxcenter and Cardialysis, Rotterdam, The Netherlands
Background: Previous studies have shown that women (W) undergoing coronary revas-
cularization (CR) have a higher incidence of in-hospital complications than men (M). To
determine whether W have an unfavorable long-term outcome after percutaneous (PCI)
or surgical (CABG) CR compared with M, we evaluated patients (pts) enrolled within the
Arterial Revascularization Therapies Study (ARTS).
Methods: We prospectively evaluated 1205 pts with angina or silent ischemia and multi-
vessel (MV) disease randomized to PCI or CABG of whom 283 (23%) were W. The clini-
cal presentation, in-hospital complications and the freedom from major adverse cardiac
and cerebrovascular events at 3-years were evaluated.
Results: W were older (65 vs 59 years), with a higher prevalence of hypertension (59%
vs 40%, p(less)0.001), hypercholestelolemia (71% vs 54%, p(less)0.001), family history
for coronary artery disease (52% vs 37%, p(less)0.001) and stable angina (64% vs 57%,
p=0.03) than M, but had a lower incidence of history of myocardial infarction (35% vs
46%, p(less)0.001) or current smoking (18% vs 30%, p(less)0.001). The presence of
unstable angina, the extent of coronary artery disease and the location of the stenosis
was similar in W and M. W assigned to CABG received the same number of arterial con-
duits and had similar number of distal anastomoses compared to M (2.5+0.7 vs 2.5+0.7
and 2.6+1.0 vs 2.8+1.1 respectively, p:ns). A higher incidence of in-hospital death (3.2%
vs 0.5%, p=0.001) and major bleeding complications (4.2% vs 1.5%, p=0.01) were
observed in W compared to M, because of increased mortality in W post-CABG
(CABG=4.1%, PCI=2.17%) and bleeding events following PCI (PCI=7.2%,
CABG=1.38%). At an average of 3 years follow-up the survival without death / cere-
brovascular accident / myocardial infarction / revascularization was similar in M and W.
(M : PCI=66.2%, CABG=83.9% ; W : PCI = 64.5%, CABG=81.4%).
Conclusion:The 3 year outcomes of W with MV disease undergoing CR are similar to
those in M. Despite the similarity in long-term outcomes, there are several gender-spe-
cific differences in clinical characteristics and risk factors profile resulting in higher in-hos-
pital complications in W.
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Gunasekaran Sengottuvel, Thierry Lefèvre, Yves Louvard, Pierre Dumas, Mehran 
Monchi, Christophe Loubeyre, Oscar Tavolaro, Marie-Claude Morice, Institut 
Cardiovasculaire Paris Sud, Massy, France
Background: Over the last several years, the number of PCI in acute myocardial infarc-
tion (AMI) has increased and stent has become an established gold standard with
increased use of Gp2b3a inhibitors as an adjunctive therapy and facilitated PCI is being
currently evaluated. The objectives of this study is to assess the evolution and trends of
PCI in AMI over the last eight years from a single center prospective registry.
Methods: Our registry started in January 1995 with pre defined strategy in AMI < 12
hours: no contra-indication regarding pre-hospital thrombolysis, direct admission in the
cathlab for immediate coronary angiogram, angioplasty when indicated and stent when
feasible.
Results: From 1995 to 2002, a total of 1824 consecutive patients underwent PCI in AMI.
They were 61.8+14.4 years, 78% males, 17% diabetes mellitus, 12% previous MI, 45%
anterior MI and 13% in cardiogenic shock. Evolution is summarized below. 
Conclusion: From 1995 to 2002, progress in PCI in AMI is remarkable with significant 
increases in pre-hospital thrombolysis, radial approach, glycoprotein IIb/IIIa inhibitors, 
stents and direct stenting. Outcome improved markedly with higher final TIMI 3 flow and 
reduced death and re-intervention.
1081-57 Randomized Comparison Between Stent and Balloon in 
Diabetic With ST-Segment Elevation Myocardial 
Infarction Undergoing Primary Angioplasty: A Substudy 
of the Zwolle-6 Randomized Trial
Giuseppe De Luca, Harry Suryapranata, Felix Zijlstra, Jan Paul Ottervanger, Arnoud WJ 
van't Hof, Jan-Henk E Dambrink, AT Marcel Gosselink, Jan CA Hoorntje, Menko-Jan de 
Boer, De Weezenlanden Hospital, Zwolle, The Netherlands
Background. Currently available randomized trials on primary stenting for ST-segment
elevation myocardial infarction (STEMI), have enrolled highly selected patients, after the
initial angiogram. In the Zwolle 6 randomized trial, 1683 patients with STEMI were ran-
domized, before angiography, to stent (S) or balloon (B), without any exclusion criteria. In
this study we present data from the subanalysis conducted in diabetic patients. 
Methods. Among a total of 1683 consecutive patients with STEMI enrolled in the study,
177 (10.5%) suffered from diabetes (S = 94 and B = 83). The primary endpoint was
MACE (death, reinfarction, and/or reintervention at 1-year).
Results. The cross-over rates from B to S and S to B were 30.3% and 20.2%, respec-
tively. No difference was observed in 1-year mortality and MACE according to intention-
to-treat analysis (see figure).
Conclusions. Our study is the first randomized trial comparing stenting and balloon
angioplasty in a large cohort of unselected, consecutive patients. This subanalysis
showed that routine stenting does not improve clinical outcome in diabetic patients
undergoing primary angioplasty for STEMI. 
1081-58 Long-Term (Seven-Year) Outcomes After Bare Metal 
Coronary Stenting for Unprotected Left Main Coronary 
Stenosis
Shinichi Shirai, Kenji Ando, Kei Nishiyama, Takashi Yamada, Jiro Ando, Masashi 
Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Masakiyo Nobuyoshi, Kokura Memorial 
Hospital, Kitakyushu, Japan
Background) Drug eluting stent may spread the indication of coronary intervention.
Therefore, the longer-term efficacy of bare metal coronary stenting for unprotected left
main coronary artery (LMCA) stenosis is necessary to be evaluated.
Methods) Between March 1991 and August 1996, 36 consecutive patients (pts) with
unprotected LMCA stenosis underwent elective stenting. Treated pts were divided into 2
groups; good candidate group (GC:17pts) for coronary artery bypass grafting(CABG),
and poor candidate group (PC 19pts) with risk factors; old age (>75 yrs) in 8pts, cere-
brovascular disease in 7 pts, prior CABG in 5 pts, poor LV (ejection fraction<40%) in 2
pts, COPD in 1 patient (pt), cancer in 1 pt, and poor run off in 1 pt. Clinical follow-up was
performed with mean interval of 64±36 months.
Results) The procedure success rate was 100%. 3-6month angiographic follow-up was
performed in 34 pts, and the restenosis rate was 21% (7/34). During the follow-up period,
thirteen pts were died (3 cardiac, 10 noncardiac). Estimated event free rate from cardiac
Endpoint Diabetes
N=263
No Diabetes
N=965
P
One-Year Outcomes
Composite 33.1% 24.6% <0.01
Death 1.1% 0.8% >0.20
MI 9.5% 7.6% >0.20
TLR 16.9% 11.0% 0.02
Other Revascularization 27.2% 19.0% <0.01
Five-Year Outcomes
Composite 58.5% 42.8% <0.01
Death 10.4% 7.7% 0.14
MI 12.2% 9.7% >0.20
Death or MI 20.9% 16.9% 0.08
New unstable angina 7.6% 4.3% 0.03
New onset CHF 3.4% 1.0% <0.01
TLR 23.2% 16.7% 0.02
Other Revascularization 34.0% 24.9% <0.01
1995-96 1997-98 1999-2000 2001- 02
Prehospital thrombolysis (% ) 13 18 18 31
GP IIbIIIa (% ) 0 5 10 11
Stent (%)
Direct Stenting (%)
84
10
90
14
92
47
95
67
Radial approach (% ) 2 10 39 55
Angiographic success (% ) 99 99 100 100
Final TIMI 3 (%) 89 89 92 95
Repeat PTCA (%) 7.0 2.9 2 2.4
In hospital Death (%) 13 10 8 8
